These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
762 related articles for article (PubMed ID: 20157160)
1. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh. Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160 [TBL] [Abstract][Full Text] [Related]
2. Campylobacter jejuni infection and Guillain-Barré syndrome. Rees JH; Soudain SE; Gregson NA; Hughes RA N Engl J Med; 1995 Nov; 333(21):1374-9. PubMed ID: 7477117 [TBL] [Abstract][Full Text] [Related]
3. Campylobacter jejuni infection in Guillain-Barré syndrome: a prospective case control study in a tertiary care hospital. Sharma A; Lal V; Modi M; Vaishnavi C; Prabhakar S Neurol India; 2011; 59(5):717-21. PubMed ID: 22019657 [TBL] [Abstract][Full Text] [Related]
4. Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barré syndrome. Sinha S; Prasad KN; Pradhan S; Jain D; Jha S Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):342-6. PubMed ID: 15099989 [TBL] [Abstract][Full Text] [Related]
5. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446 [TBL] [Abstract][Full Text] [Related]
6. Association of Campylobacter jejuni infection with childhood Guillain-Barré syndrome: a case-control study. Kalra V; Chaudhry R; Dua T; Dhawan B; Sahu JK; Mridula B J Child Neurol; 2009 Jun; 24(6):664-8. PubMed ID: 19491112 [TBL] [Abstract][Full Text] [Related]
7. Association of Campylobacter jejuni infection and GuillainBarré syndrome: a cohort study in the northwest of Iran. Barzegar M; Alizadeh A; Toopchizadeh V; Dastgiri S; Majidi J Turk J Pediatr; 2008; 50(5):443-8. PubMed ID: 19102048 [TBL] [Abstract][Full Text] [Related]
9. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome. Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757 [TBL] [Abstract][Full Text] [Related]
10. Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barré syndrome: a single centre prospective case-control study. Sinha S; Prasad KN; Jain D; Pandey CM; Jha S; Pradhan S Clin Microbiol Infect; 2007 Mar; 13(3):334-7. PubMed ID: 17391394 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis. Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan. Takahashi M; Koga M; Yokoyama K; Yuki N J Clin Microbiol; 2005 Jan; 43(1):335-9. PubMed ID: 15634991 [TBL] [Abstract][Full Text] [Related]
13. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. Nagashima T; Koga M; Odaka M; Hirata K; Yuki N Arch Neurol; 2007 Oct; 64(10):1519-23. PubMed ID: 17923636 [TBL] [Abstract][Full Text] [Related]
14. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337 [TBL] [Abstract][Full Text] [Related]
15. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419 [TBL] [Abstract][Full Text] [Related]
16. [Prevalence and characteristics of Guillain-Barré syndromes associated with Campylobacter jejuni and cytomegalovirus in greater Paris]. Sivadon V; Orlikowski D; Rozenberg F; Quincampoix JC; Caudie C; Durand MC; Fauchère JL; Sharshar T; Raphaël JC; Gaillard JL Pathol Biol (Paris); 2005; 53(8-9):536-8. PubMed ID: 16084033 [TBL] [Abstract][Full Text] [Related]
17. Guillain-Barre syndrome and Campylobacter infection. Prasad KN; Pradhan S; Nag VL Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):527-30. PubMed ID: 11944711 [TBL] [Abstract][Full Text] [Related]
18. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599 [TBL] [Abstract][Full Text] [Related]